During the past decade, Spitalul Universitar de Urgenta, Bucuresti conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Universitar de Urgenta, Bucuresti" #1 sponsor was "Amgen" with 4 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Puma Biotechnology, Inc." with 3 trials sponsored, "Eisai Limited" with 2 trials sponsored and "Helsinn Healthcare SA" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Universitar de Urgenta, Bucuresti" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Cristcot HCA LLC" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Universitar de Urgenta, Bucuresti" are "Breast Cancer" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Chronic Kidney Disease" (2 trials), "Crohn's Disease" (2 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Spitalul Universitar de Urgenta, Bucuresti" in a lesser frequency.

Most popular intervention types in "Spitalul Universitar de Urgenta, Bucuresti" are "Drug" (34 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Dexamethasone" (3 trials), "Carboplatin" (2 trials), "Neratinib" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Universitar de Urgenta, Bucuresti" are 32 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Spitalul Universitar de Urgenta, Bucuresti". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Spitalul Universitar de Urgenta, Bucuresti, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Universitar de Urgenta, Bucuresti, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".